US equities |
MU $977.64 ▲+5.26% SNDK $1,378.05 ▲+5.61% SPCX $145.55 ▼-2.04% SKHY $159.97 ▲+10.05% META $620.47 ▲+0.05% TSLA $405.29 ▼-0.53% NVDA $219.46 ▲+0.70% GOOGL $324.26 ▲+1.15%
FinancialContent

ResMed Inc. Common Stock (NY:RMD)

249.82 -0.98 (-0.39%)
Delayed Quote Updated: 9:38 AM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its... 
Via StockStory
Topics Earnings Economy
News headline image
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth
Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share... 
Via StockStory
Topics Economy
News headline image
ResMed (RMD) Q2 2026 Earnings Call Transcript ↗
ResMed (RMD) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗
Via Chartmill
ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock ↗
Via Chartmill
ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles ↗
Via Chartmill
News headline image
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share was 3.2% above... 
Via StockStory
News headline image
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what you need to know. 
Via StockStory
News headline image
1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse
In a landmark shift for preventative medicine, researchers at Stanford University have unveiled SleepFM, a pioneering multimodal AI foundation model capable of predicting over 130 different health... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?
Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11.3% gain during that period. 
Via StockStory
Topics Stocks
News headline image
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
From Resmed, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and... 
Via StockStory
Topics Stocks
News headline image
Which S&P500 stocks are moving before the opening bell on Wednesday? ↗
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy 
From Resmed, Inc.
Via GlobeNewswire
News headline image
US Stock Market Rides High: Fed Rate Cut Fuels Optimism as Indices Eye Record Peaks
New York, NY – December 10, 2025 – The U.S. stock market is currently experiencing a robust rally, with major indices positioned tantalizingly close to their all-time highs. This bullish sentiment,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
ResMed Inc. (NYSE:RMD) Offers a High-Quality Dividend Backed by Strong Fundamentals ↗
ResMed (RMD) is a high-quality dividend stock with a secure payout, strong profitability, and a rock-solid balance sheet, ideal for sustainable passive income growth. 
Via Chartmill
News headline image
Q3 2025 Earnings Showcase Corporate Resilience Amidst AI Boom, But Future Growth Faces Scrutiny
The corporate earnings landscape as of December 9, 2025, presents a complex yet compelling narrative. While the third quarter of 2025 largely concluded with robust performance across the S&P 500,... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
These S&P500 stocks that are showing activity before the opening bell on Friday. ↗
Pre-market stock analysis of S&P500 stocks on 2025-12-05: top gainers and losers in today's session. 
Via Chartmill
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory
Topics Economy
News headline image
1 Large-Cap Stock to Target This Week and 2 We Brush Off
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Discover which S&P500 stocks are making waves on Friday. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? ↗
ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader. 
Via The Motley Fool
News headline image
1 S&P 500 Stock to Research Further and 2 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >